Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death

Crit Care. 2006;10(5):424. doi: 10.1186/cc5062.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • APACHE
  • Humans
  • Protein C / therapeutic use*
  • Recombinant Proteins / therapeutic use
  • Risk Factors
  • Sepsis / drug therapy*
  • Sepsis / mortality*

Substances

  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated